Post-operatively the patient has made a remarkable recovery, and by 3 months obtained a corrected visual acuity of 6/9 + 3, which has been maintained at 6
months. The graft remains clear and functioning with healthy epithelium and no evidence of neovascularisation (Fig. 3) . He has ceased all topical treatment and has now had his driving licence restored 
Actinic keratoconjunctivitis and minocyc1ine
Minocycline is widely used as second-line therapy for acne vulgaris. It is given as a once-or twice-daily preparation and the antibiotic appears not to induce resistance. Although this tetracycline is found to be efficacious in the management of acne, it is associated with a recognised profile of side-effects. Infrequently, the eye is adversely affected by minocyc1ine.
We present the case of a patient who developed acute actinic keratoconjunctivitis secondary to minocycline use. To our knowledge this is the first report of such an interaction.
Case report 
Comment
The onset of the diffuse punctate epithelial keratitis along with the cutaneous photosensitivity reaction at light exposed areas of the face and trunk 2 weeks after starting systemic minocycline and its subsequent improvement on cessation of the drug is highly suggestive of a cause and-effect relationship. It is known that the resolution of photosensitivity may occur with either protection from the relevant radiation or drug withdrawal.1 Rechallenge with the drug was felt to be unethical considering the distressing nature of the symptoms.
The mechanism of photosensitivity remains unclear;2 however, it has been noted that some tetracyclines induce greater degrees of photosensitivity than others.
Minocycline has been regarded as the least phototoxic agent,1,3 whereas doxycycline is a more potent Minocycline has been associated with a number of ocular conditions. These include Single cases of dry eyes, conjunctivitis, eyelid swelling and cataract. Eight patients
